日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and characterization of canvuparatide, a once-weekly parathyroid hormone analog for the treatment of hypoparathyroidism

发现并鉴定了每周一次用于治疗甲状旁腺功能减退症的甲状旁腺激素类似物canvuparatide。

Zhang, Fa; Perez-Tilve, Diego; Allen, Matthew R; Metzger, Corinne E; Dorato, Michael A; Geiger, Mary Jane; DiMarchi, Richard D

Publisher Correction: GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice

出版商更正:GIPR激动剂和拮抗剂通过不同的机制降低雄性小鼠的体重和食物摄入量。

Gutgesell, Robert M; Khalil, Ahmed; Liskiewicz, Arkadiusz; Maity-Kumar, Gandhari; Novikoff, Aaron; Grandl, Gerald; Liskiewicz, Daniela; Coupland, Callum; Karaoglu, Ezgi; Akindehin, Seun; Castelino, Russell; Curion, Fabiola; Liu, Xue; Garcia-Caceres, Cristina; Cebrian-Serrano, Alberto; Douros, Jonathan D; Knerr, Patrick J; Finan, Brian; DiMarchi, Richard D; Sloop, Kyle W; Samms, Ricardo J; Theis, Fabian J; Tschöp, Matthias H; Müller, Timo D

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice.

GIPR激动剂和拮抗剂通过不同的机制降低雄性小鼠的体重和食物摄入量

Gutgesell Robert M, Khalil Ahmed, Liskiewicz Arkadiusz, Maity-Kumar Gandhari, Novikoff Aaron, Grandl Gerald, Liskiewicz Daniela, Coupland Callum, Karaoglu Ezgi, Akindehin Seun, Castelino Russell, Curion Fabiola, Liu Xue, Garcia-Caceres Cristina, Cebrian-Serrano Alberto, Douros Jonathan D, Knerr Patrick J, Finan Brian, DiMarchi Richard D, Sloop Kyle W, Samms Ricardo J, Theis Fabian J, Tschöp Matthias H, Müller Timo D

Glucose-dependent insulinotropic polypeptide (GIP)

葡萄糖依赖性促胰岛素多肽(GIP)

Müller, Timo D; Adriaenssens, Alice; Ahrén, Bo; Blüher, Matthias; Birkenfeld, Andreas L; Campbell, Jonathan E; Coghlan, Matthew P; D'Alessio, David; Deacon, Carolyn F; DelPrato, Stefano; Douros, Jonathan D; Drucker, Daniel J; Figueredo Burgos, Natalie S; Flatt, Peter R; Finan, Brian; Gimeno, Ruth E; Gribble, Fiona M; Hayes, Matthew R; Hölscher, Christian; Holst, Jens J; Knerr, Patrick J; Knop, Filip K; Kusminski, Christine M; Liskiewicz, Arkadiusz; Mabilleau, Guillaume; Mowery, Stephanie A; Nauck, Michael A; Novikoff, Aaron; Reimann, Frank; Roberts, Anna G; Rosenkilde, Mette M; Samms, Ricardo J; Scherer, Philip E; Seeley, Randy J; Sloop, Kyle W; Wolfrum, Christian; Wootten, Denise; DiMarchi, Richard D; Tschöp, Matthias H

A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans

每日一次的GLP-1/GIP/胰高血糖素受体三激动剂(NN1706)可降低啮齿动物、猴子和人类的体重。

Finan, Brian; Douros, Jonathan D; Goldwater, Ronald; Hansen, Ann Maria Kruse; Hjerpsted, Julie B; Hjøllund, Karina Rahr; Kankam, Martin K; Knerr, Patrick J; Konkar, Anish; Mowery, Stephanie A; Müller, Timo D; Nielsen, John Rømer; Nygård, Sune Boris; Perez-Tilve, Diego; Raun, Kirsten; Yang, Bin; Tschöp, Matthias H; DiMarchi, Richard D

Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

更正:在心血管代谢疾病的临床前小鼠模型中,GIP受体激动剂可独立于体重减轻改善血脂异常和动脉粥样硬化。

Sachs, Stephan; Götz, Anna; Finan, Brian; Feuchtinger, Annette; DiMarchi, Richard D; Döring, Yvonne; Weber, Christian; Tschöp, Matthias H; Müller, Timo D; Hofmann, Susanna M

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

在心血管代谢疾病的临床前小鼠模型中,GIP受体激动剂可独立于体重减轻改善血脂异常和动脉粥样硬化。

Sachs, Stephan; Götz, Anna; Finan, Brian; Feuchtinger, Annette; DiMarchi, Richard D; Döring, Yvonne; Weber, Christian; Tschöp, Matthias H; Müller, Timo D; Hofmann, Susanna M

Anti-obesity drug discovery: advances and challenges

抗肥胖药物研发:进展与挑战

Müller, Timo D; Blüher, Matthias; Tschöp, Matthias H; DiMarchi, Richard D

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice

新一代GLP-1/GIP/胰高血糖素三重激动剂可使肥胖小鼠的体重恢复正常

Knerr, Patrick J; Mowery, Stephanie A; Douros, Jonathan D; Premdjee, Bhavesh; Hjøllund, Karina Rahr; He, Yantao; Kruse Hansen, Ann Maria; Olsen, Anette K; Perez-Tilve, Diego; DiMarchi, Richard D; Finan, Brian

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

基于肠促胰素的药物疗法在肥胖症和糖尿病治疗中的最新进展

Tan, Qiming; Akindehin, Seun E; Orsso, Camila E; Waldner, Richelle C; DiMarchi, Richard D; Müller, Timo D; Haqq, Andrea M